Evidence map›Paper›PMID 25355923›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Proprotein convertase FURIN constrains Th2 differentiation and is critical for host resistance against Toxoplasma gondii.

Anna Oksanen, Saara Aittomäki, Dragana Jankovic, Zsuzsanna Ortutay, Kati Pulkkinen, Sanna Hämäläinen, Anne Rokka, Garry L Corthals, Wendy T Watford, Ilkka Junttila and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Anna OksanenLaboratory of Immunoregulation, BioMediTech, University of Tampere, 33014 Tampere, Finland;
Saara AittomäkiLaboratory of Immunoregulation, BioMediTech, University of Tampere, 33014 Tampere, Finland;
Dragana JankovicImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
Zsuzsanna OrtutayLaboratory of Immunoregulation, BioMediTech, University of Tampere, 33014 Tampere, Finland;
Kati PulkkinenLaboratory of Immunoregulation, BioMediTech, University of Tampere, 33014 Tampere, Finland;
Sanna HämäläinenLaboratory of Immunoregulation, BioMediTech, University of Tampere, 33014 Tampere, Finland;
Anne RokkaTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20520 Turku, Finland;
Garry L CorthalsTurku Centre for Biotechnology, University of Turku and Åbo Akademi University, 20520 Turku, Finland; Van't Hoff Institute for Molecular Sciences, University of Amsterdam, 1090 GD Amsterdam, the Netherlands;
Wendy T WatfordLymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602;
Ilkka JunttilaFimlab Laboratories, Pirkanmaa Hospital District, 33101 Tampere, Finland; School of Medicine, University of Tampere, 33014 Tampere, Finland; and.
John J O'SheaLymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892;
Marko PesuLaboratory of Immunoregulation, BioMediTech, University of Tampere, 33014 Tampere, Finland; Fimlab Laboratories, Pirkanmaa Hospital District, 33101 Tampere, Finland; Department of Dermatology, Pirkanmaa Hospital District, 33101 Tampere, Finland marko.pesu@uta.fi.
Tampere University · FINational Institutes of Health · USTampere University · FIPirkanmaa Hospital District · FITurku Centre for Biotechnology · FIUniversity of Amsterdam · NL

Funding

Stat transcription factors in immunoregulation and autoimmune diseaseZIAAR041159 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2025
$49.3M
Immune Regulation In Toxoplasmosis And Other Opportunistic InfectionsZIAAI000579 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHER, ALAN · 2009 to 2022
$7.8M
Furin as a Stat-dependent regulator of autoimmunityZ01AR041160 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2008 to 2008
$260k
Intramural NIH HHS Z01 AR041160
6 · The paper itself

Abstract

The proprotein convertase subtilisin/kexin enzymes proteolytically convert immature proproteins into bioactive molecules, and thereby they serve as key regulators of cellular homeostasis. The archetype proprotein convertase subtilisin/kexin, FURIN, is a direct target gene of the IL-12/STAT4 pathway and it is upregulated in Th1 cells. We have previously demonstrated that FURIN expression in T cells critically regulates the maintenance of peripheral immune tolerance and the functional maturation of pro-TGF-β1 in vivo, but FURIN's role in cell-mediated immunity and Th polarization has remained elusive. In this article, we show that T cell-expressed FURIN is essential for host resistance against a prototypic Th1 pathogen, Toxoplasma gondii, and for the generation of pathogen-specific Th1 lymphocytes, including Th1-IL-10 cells. FURIN-deficient Th cells instead show elevated expression of IL-4R subunit α on cell surface, sensitized IL-4/STAT6 signaling, and a propensity to polarize toward the Th2 phenotype. By exploring FURIN-interacting proteins in Jurkat T cells with Strep-Tag purification and mass spectrometry, we further identify an association with a cytoskeleton modifying Ras-related C3 botulinum toxin substrate/dedicator of cytokinesis 2 protein complex and unravel that FURIN promotes F-actin polymerization, which has previously been shown to downregulate IL-4R subunit α cell surface expression and promote Th1 responses. In conclusion, our results demonstrate that in addition to peripheral immune tolerance, T cell-expressed FURIN is also a central regulator of cell-mediated immunity and Th1/2 cell balance.

Indexed as

ActinsCell DifferentiationCytokinesFurinGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsHumansImmune ToleranceImmunityJurkat CellsProtein Bindingrac1 GTP-Binding ProteinSignal TransductionSTAT4 Transcription FactorSTAT6 Transcription FactorTh1 CellsActinsCytokinesDOCK2 protein, humanFurinGTPase-Activating ProteinsGuanine Nucleotide Exchange Factorsrac1 GTP-Binding ProteinSTAT4 Transcription FactorSTAT6 Transcription Factor

Identifiers

PMID25355923
PMCPMC4261955
OpenAlexW1532350838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.